Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Esophageal Squamous Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07312578
What this trial is testing

Nimotuzumab,Camrelizumab, and Neoadjuvant Chemotherapy（nCT） in the Treatment of Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Peking University 48
Not applicableLooking for participantsNCT07050576
What this trial is testing

Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma

Who this might be right for
ESCCLymph Node MetastasisRadiomics
The First Affiliated Hospital of Anhui Medical University 500
Testing effectiveness (Phase 2)Looking for participantsNCT07162506
What this trial is testing

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Testing effectiveness (Phase 2)UnknownNCT01993784
What this trial is testing

Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma.

Who this might be right for
Esophageal Squamous Cell Cancer
Peking University 9
Testing effectiveness (Phase 2)Looking for participantsNCT07061704
What this trial is testing

Oncolytic Virus in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Sichuan University 40
Testing effectiveness (Phase 2)Looking for participantsNCT05978193
What this trial is testing

Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEsophageal CancerMetastatic Esophageal Squamous Cell Carcinoma
Shanghai Chest Hospital 100
Not applicableStudy completedNCT01748942
What this trial is testing

Dexamethasone in Reducing Oral Pain and Dry Mouth After Surgery in Patients With Oropharyngeal Cancer

Who this might be right for
DysphagiaPainStage I Oropharyngeal Squamous Cell Carcinoma+2 more
OHSU Knight Cancer Institute 76
Post-approval studies (Phase 4)UnknownNCT03180970
What this trial is testing

Different Lugol's Solution Concentration for Image Quality of Esophageal Lesions in Chromoendoscopy With Iodine Staining

Who this might be right for
Image Quality of Early Esophageal Squamous NeoplasiaEndoscopists'Subjective Assessments
Shandong University 50
Testing effectiveness (Phase 2)UnknownNCT03791905
What this trial is testing

PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

Who this might be right for
Neoplasm, EsophagealSquamous Cell Carcinoma
Mian XI 216
Early research (Phase 1)Looking for participantsNCT05984342
What this trial is testing

Adjuvant Chemotherapy in Combination With Tislelizumab in Lymph Node-Positive Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Affiliated Cancer Hospital of Shantou University Medical College 50
Not applicableUnknownNCT04654403
What this trial is testing

Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Cancer
The First Affiliated Hospital of Zhengzhou University 337
Early research (Phase 1)Active Not RecruitingNCT06781983
What this trial is testing

Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Innate Pharma 145
Testing effectiveness (Phase 2)Looking for participantsNCT07435454
What this trial is testing

Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Jiangsu Cancer Institute & Hospital 22
Not applicableLooking for participantsNCT02972372
What this trial is testing

Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer

Who this might be right for
Esophagus Cancer
The First Affiliated Hospital of Henan University of Science and Technology 196
Testing effectiveness (Phase 2)UnknownNCT04437212
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer

Who this might be right for
Advanced Esophageal Squamous Cell Cancer
RenJi Hospital 20
Not applicableUnknownNCT06410677
What this trial is testing

Changhai Multimodal Esophageal Cancer Cohort

Who this might be right for
Esophageal Squamous Cell Carcinoma
Wangluowei 110
Testing effectiveness (Phase 2)UnknownNCT05626569
What this trial is testing

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaOligometastatic Disease
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT03719924
What this trial is testing

Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma
Federation Francophone de Cancerologie Digestive 106
Testing effectiveness (Phase 2)UnknownNCT05394415
What this trial is testing

Chemoradiation Plus Tislelizumab for Conversion Therapy of Locally Nonresectable ESCC

Who this might be right for
Esophageal Squamous Cell CarcinomaTislelizumabChemoradiation
Jiangsu Cancer Institute & Hospital 30
Next Page